Hims & Hers Health, Inc. (HIMS), a health and wellness platform, on Thursday announced the appointment of Anant Vinjamoori as Chief Medical Officer of its Hims brand.
Vinjamoori will provide clinical guidance for the Hims brand across sexual health, hormone health, dermatology, weight loss, mental health, and emerging areas including longevity medicine and peptide therapy.
Vinjamoori brings more than a decade of clinical and executive experience in internal medicine, primary care, and longevity medicine.
Previously, Vinjamoori held leadership roles at Virta Health and Modern Age and founded Next Generation Medicine.
Vinjamoori will join the company's medical leadership team led by Global Chief Medical Officer Pat Carroll.
In the pre-market trading, Hims & Hers Health is 2% lesser at $26.97 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.